Cost is a real and legitimate consideration in evaluating regenerative treatment — worth discussing transparently, alongside (not instead of) the evidence and regulatory context covered throughout this site.
A higher price does not indicate stronger evidence or better regulatory standing, and a lower price doesn't necessarily indicate lower quality either. Cost should be evaluated separately from — not as a substitute for — the evidence and provider-vetting questions covered elsewhere on this site.
What affects cost
- Treatment type — stem cell vs. exosome vs. PRP (see our comparison guide) carry different production and sourcing costs
- Number of joints or areas treated
- Sourcing method (bone marrow vs. adipose-derived — see our sourcing guide)
- Whether imaging and follow-up visits are included in the quoted price
What to ask for in a transparent quote
Confirm exactly what's included — initial evaluation, the treatment itself, and any follow-up visits — and ask specifically what happens if additional sessions are recommended after your first treatment, since this is common in regenerative medicine protocols.
Comparing this to US pricing
Given the largely unregulated, cash-pay nature of this treatment category in both countries, US pricing for comparable treatments varies enormously — a direct international cost comparison is less standardized here than for most other medical tourism categories, worth researching carefully on a clinic-by-clinic basis rather than assuming a fixed "savings percentage."
Ready to talk to someone?
Message us on WhatsApp for a free, no-obligation consultation.